Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
ipilimumab (yervoy) (1 trial)
sargramostim (leukine) (1 trial)
Melanoma (Phase 2)
Trials (1 total)
Trial APIs (2 total)